|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 5/04/21 Omega Healthcare Investors Inc. 10-Q 3/31/21 96:12M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.53M
2: EX-22.1 Published Report re: Matters Submitted to a Vote HTML 27K
of Security Holders
3: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 27K
6: EX-32.2 Certification -- §906 - SOA'02 HTML 27K
13: R1 Document and Entity Information HTML 78K
14: R2 Consolidated Balance Sheets HTML 131K
15: R3 Consolidated Balance Sheets (Parentheticals) HTML 42K
16: R4 Consolidated Statements of Operations HTML 116K
17: R5 Consolidated Statements of Comprehensive Income HTML 54K
18: R6 Consolidated Statements of Changes in Equity HTML 98K
19: R7 Consolidated Statements of Changes in Equity HTML 27K
(Parentheticals)
20: R8 Consolidated Statements of Cash Flows HTML 140K
21: R9 Basis of Presentation and Significant Accounting HTML 101K
Policies
22: R10 Properties and Investments HTML 86K
23: R11 Mortgage Notes Receivable HTML 52K
24: R12 Other Investments HTML 54K
25: R13 Allowance for Credit Losses HTML 209K
26: R14 Variable Interest Entities HTML 124K
27: R15 Investments in Joint Ventures HTML 101K
28: R16 Assets Held for Sale HTML 40K
29: R17 Intangibles HTML 57K
30: R18 Concentration of Risk HTML 28K
31: R19 Stockholders Equity HTML 96K
32: R20 Taxes HTML 33K
33: R21 Stock-Based Compensation HTML 36K
34: R22 Borrowing Activities and Arrangements HTML 172K
35: R23 Financial Instruments HTML 114K
36: R24 Commitments and Contingencies HTML 48K
37: R25 Earnings Per Share HTML 62K
38: R26 Supplemental Disclosure to Consolidated Statements HTML 56K
of Cash Flows
39: R27 Subsequent Events HTML 29K
40: R28 Basis of Presentation and Significant Accounting HTML 136K
Policies (Policy)
41: R29 Basis of Presentation and Significant Accounting HTML 46K
Policies (Tables)
42: R30 Properties and Investments (Tables) HTML 87K
43: R31 Mortgage Notes Receivable (Tables) HTML 52K
44: R32 Other Investments (Tables) HTML 54K
45: R33 Allowance for Credit Losses (Tables) HTML 211K
46: R34 Variable Interest Entities (Tables) HTML 128K
47: R35 INVESTMENT IN JOINT VENTUREs (Tables) HTML 99K
48: R36 Assets Held for Sale (Tables) HTML 40K
49: R37 Intangibles (Tables) HTML 58K
50: R38 Stockholders Equity (Tables) HTML 100K
51: R39 Stock-Based Compensation (Tables) HTML 35K
52: R40 Borrowing Activities and Arrangements (Tables) HTML 168K
53: R41 Financial Instruments (Tables) HTML 106K
54: R42 Commitments and Contingencies (Tables) HTML 36K
55: R43 Earnings Per Share (Tables) HTML 61K
56: R44 Supplemental Disclosure to Consolidated Statements HTML 55K
of Cash Flows (Tables)
57: R45 Basis of Presentation and Significant Accounting HTML 144K
Policies (Narrative) (Detail)
58: R46 Basis of Presentation and Significant Accounting HTML 36K
Policies (Accounts Receivable) (Detail)
59: R47 Properties and Investments (Leased Property) HTML 35K
(Narrative) (Detail)
60: R48 Properties and Investments (Summary of our HTML 43K
investment in leased real estate properties)
(Details)
61: R49 Properties and Investments (Schedule of operating HTML 32K
lease income) (Details)
62: R50 Properties and Investments (Schedule of HTML 53K
Significant Acquisitions) (Detail)
63: R51 Properties and Investments (Asset Sales and HTML 43K
Impairments) (Narrative) (Detail)
64: R52 Mortgage Notes Receivable (Narrative) (Detail) HTML 43K
65: R53 Mortgage Notes Receivable (Schedule of HTML 64K
Receivables) (Detail)
66: R54 Other Investments (Schedule of Receivables) HTML 60K
(Details)
67: R55 Other Investments (Notes Due 2024 Narrative) HTML 50K
(Detail)
68: R56 Allowance for Credit Losses (Schedule of expected HTML 76K
credit loss per segment) (Detail)
69: R57 Allowance for Credit Losses (Schedule by segment HTML 78K
balance by vintage and credit quality indicator)
(Detail)
70: R58 Variable Interest Entities (Schedule of Variable HTML 105K
Interest Entities) (Detail)
71: R59 INVESTMENT IN JOINT VENTUREs (Narrative) (Details) HTML 29K
72: R60 INVESTMENT IN JOINT VENTUREs (Schedule of equity HTML 117K
method investments) (Details)
73: R61 Assets Held for Sale (Schedule of Properties HTML 60K
Held-for-Sale) (Details)
74: R62 Intangibles (Narrative) (Details) HTML 40K
75: R63 Intangibles (Schedule of Intangibles) (Detail) HTML 41K
76: R64 Intangibles (Schedule of Reconciliation of HTML 30K
Goodwill) (Detail)
77: R65 Concentration of Risk (Narrative) (Detail) HTML 77K
78: R66 Stockholders Equity (Schedule of Common Stock HTML 36K
Dividends) (Details)
79: R67 Stockholders Equity (Equity Shelf Program Schedule HTML 33K
and Narrative) (Detail)
80: R68 Stockholders Equity (Schedule of dividend HTML 29K
reinvestment and common stock purchase plan)
(Detail)
81: R69 Stockholders Equity (Schedule of Accumulated Other HTML 77K
Comprehensive Income (Loss)) (Details)
82: R70 Taxes (Narrative) (Detail) HTML 42K
83: R71 Stock-Based Compensation (Narrative) (Details) HTML 34K
84: R72 Stock-Based Compensation (Schedule of Stock-based HTML 27K
Compensation Expense) (Details)
85: R73 Borrowing Activities and Arrangements (Schedule of HTML 163K
Borrowings) (Details)
86: R74 Borrowing Activities and Arrangements (Forward HTML 68K
Starting Swaps) (Details)
87: R75 Financial Instruments (Schedule of Financial HTML 101K
Instruments) (Details)
88: R76 Commitments and Contingencies (Narrative) HTML 41K
(Details)
89: R77 Commitments and Contingencies (Schedule of HTML 31K
remaining commitments) (Detail)
90: R78 Earnings Per Share (Schedule of Computation of HTML 69K
Basic and Diluted Earnings per Share) (Detail)
91: R79 Supplemental Disclosure to Consolidated Statements HTML 47K
of Cash Flows (Detail)
92: R80 Subsequent Events (Narrative) (Details) HTML 43K
94: XML IDEA XML File -- Filing Summary XML 181K
12: XML XBRL Instance -- ohi-20210331x10q_htm XML 3.88M
93: EXCEL IDEA Workbook of Financial Reports XLSX 137K
8: EX-101.CAL XBRL Calculations -- ohi-20210331_cal XML 219K
9: EX-101.DEF XBRL Definitions -- ohi-20210331_def XML 856K
10: EX-101.LAB XBRL Labels -- ohi-20210331_lab XML 1.49M
11: EX-101.PRE XBRL Presentations -- ohi-20210331_pre XML 1.34M
7: EX-101.SCH XBRL Schema -- ohi-20210331 XSD 239K
95: JSON XBRL Instance as JSON Data -- MetaLinks 461± 696K
96: ZIP XBRL Zipped Folder -- 0000888491-21-000013-xbrl Zip 333K
Exhibit 32.1
SECTION 1350 CERTIFICATION
OF THE CHIEF EXECUTIVE OFFICER
I, C. Taylor Pickett, Chief Executive Officer of Omega Healthcare Investors, Inc. (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge:
(1) the Quarterly Report on Form 10-Q of the Company for the three months ended March 31, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | |
Date: | | |
| | |
/s/ | | |
| | |
| Chief Executive Officer | |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/4/21 | 4, 8-K | ||
| For Period end: | 3/31/21 | 4 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/07/21 Omega Healthcare Investors Inc. S-3ASR 12/07/21 7:2M Toppan Merrill/FA 11/05/21 Omega Healthcare Investors Inc. 10-Q 9/30/21 106:16M 8/05/21 Omega Healthcare Investors Inc. 424B5 1:688K Toppan Merrill/FA 8/03/21 Omega Healthcare Investors Inc. 10-Q 6/30/21 102:15M 5/20/21 Omega Healthcare Investors Inc. 424B2 1:437K Toppan Merrill/FA 5/13/21 Omega Healthcare Investors Inc. S-3ASR 5/13/21 4:364K Toppan Merrill/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/14/21 Omega Healthcare Investors Inc. 8-K:5,9 4/08/21 11:380K Toppan Merrill/FA 3/10/21 Omega Healthcare Investors Inc. 8-K:1,2,9 3/10/21 14:1M Toppan Merrill/FA 2/22/21 Omega Healthcare Investors Inc. 10-K 12/31/20 142:28M |